H.C. Wainwright lifts Halozyme stock price target to $95
Corroborated by 2 sources from 2 publishers
globalcrime3h ago
TL;DR
Legend Biotech Corp.
Sources
1
Investing.com News
https://www.investing.com/news/analyst-ratings/hc-wainwright-raises-halozyme-stock-price-target-to-95-93CH-4644649
4h ago
2
Investing.com News
https://www.investing.com/news/analyst-ratings/hc-wainwright-raises-relay-therapeutics-stock-price-target-to-25-93CH-4644660
4h ago
3
Investing.com News
https://www.investing.com/news/analyst-ratings/hc-wainwright-raises-axogen-stock-price-target-to-50-on-revenue-beat-93CH-4644661
4h ago
4
Investing.com News
https://www.investing.com/news/analyst-ratings/hc-wainwright-raises-black-diamond-stock-price-target-on-trial-data-93CH-4644663
4h ago
5
Yahoo Finance News
https://finance.yahoo.com/sectors/healthcare/articles/h-c-wainwright-reaffirms-buy-131725045.html
3h ago